Latest filing published 10 Feb 2026 for AMGEN INC, €310k.
Insider track record
James E. Bradner: trading record in brief
All filings by James E. Bradner on record concern Amgen Inc. Over a trading history stretching from 9 February 2024 to 9 February 2026, the count stands at 6 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 10 February 2026: a share grant of €310k, in Amgen Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James E. Bradner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 953 shares@ US$384.3230.7% of flowCommon StockSEC:0000318154-26-000006:1
- 2,151 shares@ US$384.3269.3% of flowCommon StockSEC:0000318154-26-000006:0
- 3,549 shares0Common StockSEC:0001127602-25-013778:0
- 2,863 shares0Common StockSEC:0001127602-24-014850:0
- 8,587 shares0Common StockSEC:0001127602-24-004620:0
5 of 5 declarations
